申请人:Haydar Simon N.
公开号:US20090181952A1
公开(公告)日:2009-07-16
The present invention provides compounds and compositions, and methods of using them to modulate α7 nicotinic acetylcholine receptors and/or to treat any of a variety of disorders, diseases, and conditions. Provided compounds can affect, among other things, neurological, psychiatric and/or inflammatory systems.
本发明提供了化合物和组合物,以及使用它们调节α7烟碱性乙酰胆碱受体和/或治疗各种紊乱、疾病和情况的方法。所提供的化合物可以影响神经系统、精神疾病和/或炎症系统等方面。